In two recent decisions, the Madras High Court reversed patent application rejections under Section 3(i), clarifying that only diagnostic methods disclosing pathology per se fall within the exclusion. The Court remanded matters for fresh review, ensuring fair consideration and reasoned decisions by the IPO.
Read more about Section 3(i) Rejections Reversed: Diagnostic Methods Must Disclose Pathology Per SeTag: diagnostic methods
Patentability of scientific principles and natural relationships in the light of Laboratory Corp. v Metabolite
This article analyses the legal boundaries for patenting scientific principles and natural relationships, with a focus on the Laboratory Corp v Metabolite case. It explores US Supreme Court jurisprudence and the ongoing debate over patent eligibility in diagnostic methods and biotechnology.
Read more about Patentability of scientific principles and natural relationships in the light of Laboratory Corp. v Metabolite